5/28
08:24 am
vtvt
CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING [Yahoo! Finance]
High
Report
CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING [Yahoo! Finance]
5/28
08:00 am
vtvt
CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING
High
Report
CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING
5/27
10:39 am
vtvt
Shareholders in vTv Therapeutics (NASDAQ:VTVT) are in the red if they invested three years ago [Yahoo! Finance]
High
Report
Shareholders in vTv Therapeutics (NASDAQ:VTVT) are in the red if they invested three years ago [Yahoo! Finance]
5/20
12:16 pm
vtvt
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF PANCREATIC CANCER [Yahoo! Finance]
Medium
Report
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF PANCREATIC CANCER [Yahoo! Finance]
5/20
12:00 pm
vtvt
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF PANCREATIC CANCER
Medium
Report
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF PANCREATIC CANCER
5/14
12:10 am
vtvt
vTv Therapeutics Inc. (NASDAQ: VTVT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
vTv Therapeutics Inc. (NASDAQ: VTVT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
5/9
05:01 pm
vtvt
vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update [Yahoo! Finance]
5/9
04:51 pm
vtvt
vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
Medium
Report
vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
5/9
04:33 pm
vtvt
Form 10-Q vTv Therapeutics Inc. For: Mar 31
Medium
Report
Form 10-Q vTv Therapeutics Inc. For: Mar 31
5/9
04:28 pm
vtvt
Form 8-K vTv Therapeutics Inc. For: May 09
Medium
Report
Form 8-K vTv Therapeutics Inc. For: May 09
4/30
06:09 am
vtvt
Form EFFECT vTv Therapeutics Inc.
Low
Report
Form EFFECT vTv Therapeutics Inc.
4/29
04:30 pm
vtvt
Form 424B2 vTv Therapeutics Inc.
Low
Report
Form 424B2 vTv Therapeutics Inc.
4/29
04:27 pm
vtvt
Form 424B2 vTv Therapeutics Inc.
Low
Report
Form 424B2 vTv Therapeutics Inc.
4/25
04:24 pm
vtvt
Form DEF 14A vTv Therapeutics Inc. For: Jun 11
Medium
Report
Form DEF 14A vTv Therapeutics Inc. For: Jun 11
4/10
05:11 pm
vtvt
Form S-3 vTv Therapeutics Inc.
Low
Report
Form S-3 vTv Therapeutics Inc.
3/26
04:36 pm
vtvt
Form 8-K vTv Therapeutics Inc. For: Mar 25
Medium
Report
Form 8-K vTv Therapeutics Inc. For: Mar 25
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register